Intestinal barrier integrity enhancer

Intestinal barrier integrity enhancer" is not a specific molecule or receptor but rather a functional description applied to any agent—such as small molecules, dietary components like quercetin, probiotics including certain bacterial metabolites—that improves the structure and function of the intestinal epithelial barrier. The healthy intestinal barrier relies on tightly regulated intercellular junctions between epithelial cells; disruption leads to increased permeability ("leaky gut"), which is implicated in inflammatory bowel disease and other systemic conditions. Agents described as "intestinal barrier integrity enhancers" act by upregulating key structural proteins at these junctions (such as claudins and occludin), modulating cell survival/proliferation pathways like PI3K/AKT or Wnt/β-catenin[1][4], reducing inflammation-induced damage to the epithelium[1][3], or promoting mucus production. Because this term does not refer to a single molecular entity but rather a class of activities/mechanisms across diverse compounds and interventions—including drugs, dietary supplements, probiotics—it should not be considered a canonical therapeutic target itself. In summary: "Intestinal barrier integrity enhancer" is an imprecise label describing agents that improve gut lining function; it is not itself a defined molecular target such as an enzyme or receptor.[2]

Upregulation of tight junction proteins (e.g., claudins, occludin, ZO proteins); Modulation of signaling pathways such as PI3K/AKT and Wnt/β-catenin; Reduction in inflammation-induced permeability by suppressing pro-inflammatory signaling (e.g., TNF-alpha effects)